Loading...

Timothy R Morgan

Title(s)Professor In Residence, Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(562) 826-5756
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Southern California Alcoholic Hepatitis Consortium Administrative Core
    NIH/NIAAA U01AA021884Sep 20, 2013 - Aug 31, 2018
    Role: Principal Investigator
    A prospective, randomized, clinical trial to evaluate two novel therapies, mycoph
    NIH/NIAAA U01AA021886Sep 20, 2013 - Aug 31, 2018
    Role: Principal Investigator
    Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study
    NIH/NIAAA U01AA018389Sep 20, 2011 - Jun 30, 2020
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers. Am J Gastroenterol. 2020 Aug 31. Whitfield JB, Masson S, Liangpunsakul S, Mueller S, Aithal GP, Eyer F, Gleeson D, Thompson A, Stickel F, Soyka M, Daly AK, Cordell HJ, Foroud T, Lumeng L, Pirmohamed M, Nalpas B, Jacquet JM, Moirand R, Nahon P, Naveau S, Perney P, Haber PS, Seitz HK, Day CP, Mathurin P, Morgan TR, Seth D. PMID: 32868629.
      View in: PubMed   Mentions:    Fields:    
    2. Genome-wide association study and meta-analysis on alcohol-related liver cirrhosis identifies novel genetic risk factors. Hepatology. 2020 Aug 27. Schwantes-An TH, Darlay R, Mathurin P, Masson S, Liangpunsakul S, Mueller S, Aithal GP, Eyer F, Gleeson D, Thompson A, Muellhaupt B, Stickel F, Soyka M, Goldman D, Liang T, Lumeng L, Pirmohamed M, Nalpas B, Jacquet JM, Moirand R, Nahon P, Naveau S, Perney P, Botwin G, Haber PS, Seitz HK, Day CP, Foroud TM, Daly AK, Cordell HJ, Whitfield JB, Morgan TR, Seth D. PMID: 32853455.
      View in: PubMed   Mentions:    Fields:    
    3. A comparison of psychological resilience and related factors in Chinese firstborn and only children. Asian J Psychiatr. 2020 Aug 23; 53:102360. Morgan T, Yang S, Liu B, Cao Y. PMID: 32871400.
      View in: PubMed   Mentions:    Fields:    
    4. Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis. Hepatology. 2020 Jun; 71(6):2080-2092. Rogal S, Youk A, Zhang H, Gellad WF, Fine MJ, Good CB, Chartier M, DiMartini A, Morgan T, Bataller R, Kraemer KL. PMID: 31758811.
      View in: PubMed   Mentions: 1     Fields:    
    5. Strategy Configurations Directly Linked to Higher Hepatitis C Virus Treatment Starts: An Applied Use of Configurational Comparative Methods. Med Care. 2020 05; 58(5):e31-e38. Yakovchenko V, Miech EJ, Chinman MJ, Chartier M, Gonzalez R, Kirchner JE, Morgan TR, Park A, Powell BJ, Proctor EK, Ross D, Waltz TJ, Rogal SS. PMID: 32187105.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Differential Activation of Unconventional T Cells, Including iNKT Cells, in Alcohol-Related Liver Disease. Alcohol Clin Exp Res. 2020 05; 44(5):1061-1074. Marrero I, Maricic I, Morgan TR, Stolz AA, Schnabl B, Liu ZX, Tsukamoto H, Kumar V. PMID: 32154597.
      View in: PubMed   Mentions:    Fields:    
    7. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020 Feb; 71(2):686-721. Ghany MG, Morgan TR. PMID: 31816111.
      View in: PubMed   Mentions: 6     Fields:    
    8. A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index. Cancer Prev Res (Phila). 2020 02; 13(2):203-212. Zell JA, McLaren CE, Morgan TR, Lawson MJ, Rezk S, Albers CG, Chen WP, Carmichael JC, Chung J, Richmond E, Rodriguez LM, Szabo E, Ford LG, Pollak MN, Meyskens FL. PMID: 31818851.
      View in: PubMed   Mentions: 1     Fields:    
    9. Alanine Aminotransferase Results Differ by Analyzer Manufacturer in a National Integrated Health Setting, 2012-2017. Arch Pathol Lab Med. 2020 Jun; 144(6):748-754. Beste LA, Icardi M, Hunt CM, Gylys-Colwell I, Lowy E, Taylor L, Morgan TR, Chang MF, Maier MM, Cheung R. PMID: 31697169.
      View in: PubMed   Mentions:    Fields:    
    10. Access to Comprehensive Services for Advanced Liver Disease in the Veterans Health Administration. Dig Dis Sci. 2019 12; 64(12):3471-3479. Dunn SH, Rogal SS, Maier MM, Chartier M, Morgan TR, Beste LA. PMID: 31432344.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis C treatment: Year 2. Implement Sci. 2019 04 08; 14(1):36. Rogal SS, Yakovchenko V, Waltz TJ, Powell BJ, Gonzalez R, Park A, Chartier M, Ross D, Morgan TR, Kirchner JE, Proctor EK, Chinman MJ. PMID: 30961615.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. The Veterans Affairs Hepatitis C Treatment Considerations. Am J Gastroenterol. 2019 02; 114(2):185-188. Yee HS, Burton MJ, Belperio PS, Morgan TR. PMID: 30315291.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    13. Will Studies in Nonalcoholic Steatohepatitis Help Manage Alcoholic Steatohepatitis? Clin Liver Dis. 2019 02; 23(1):157-165. Sundaram V, Morgan TR. PMID: 30454829.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals. J Virus Erad. 2019 Jan 01; 5(1):60-66. Popping S, Bade D, Boucher C, van der Valk M, El-Sayed M, Sigurour O, Sypsa V, Morgan T, Gamkrelidze A, Mukabatsinda C, Deuffic-Burban S, Ninburg M, Feld J, Hellard M, Ward J. PMID: 30800429.
      View in: PubMed   Mentions:
    15. Characteristics of Opioid Prescriptions to Veterans With Cirrhosis. Clin Gastroenterol Hepatol. 2019 05; 17(6):1165-1174.e3. Rogal SS, Beste LA, Youk A, Fine MJ, Ketterer B, Zhang H, Leipertz S, Chartier M, Good CB, Kraemer KL, Chinman M, Morgan T, Gellad WF. PMID: 30342261.
      View in: PubMed   Mentions: 1     Fields:    
    16. Controversies in early liver transplantation for severe alcoholic hepatitis. Ann Hepatol. 2018 Aug 24; 17(5):759-768. Wu T, Morgan TR, Klein AS, Volk ML, Saab S, Sundaram V. PMID: 30145578.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Screening and Treating Hepatitis C in the VA: Achieving Excellence Using Lean and System Redesign. Fed Pract. 2018 Jul; 35(7):24-29. Park A, Gonzalez R, Chartier M, Rogal S, Yakovchenko V, Ross D, Morgan TR. PMID: 30766371.
      View in: PubMed   Mentions:
    18. Is Granulocyte Colony Stimulating Factor a New Treatment for Alcoholic Hepatitis? Clin Gastroenterol Hepatol. 2018 10; 16(10):1564-1565. Morgan TR. PMID: 29913276.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success. Infect Dis Clin North Am. 2018 06; 32(2):281-292. Belperio PS, Chartier M, Gonzalez RI, Park AM, Ross DB, Morgan TR, Backus LI. PMID: 29778256.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    20. Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials. Gastroenterology. 2018 08; 155(2):458-468.e8. Louvet A, Thursz MR, Kim DJ, Labreuche J, Atkinson SR, Sidhu SS, O'Grady JG, Akriviadis E, Sinakos E, Carithers RL, Ramond MJ, Maddrey WC, Morgan TR, Duhamel A, Mathurin P. PMID: 29738698.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    21. Hepatitis A Virus Prevention and Vaccination Within and Outside the Veterans Health Administration in Light of Recent Outbreaks. Fed Pract. 2018 Mar; 35(Suppl 2):S32-S37. Moon AM, Lowy E, Maier MM, Chartier M, Morgan TR, Hoffman-Högg L, Beste LA. PMID: 30766392.
      View in: PubMed   Mentions:
    22. Achieving Excellence in Hepatitis B Virus Care for Veterans in the Veterans Health Administration. Fed Pract. 2018 Mar; 35(Suppl 2):S49-S53. Chartier M, Maier MM, Morgan TR, Lowy E, Hoffman-Högg L, Ross D, Beste LA. PMID: 30766394.
      View in: PubMed   Mentions:
    23. Extracorporeal liver assist device for alcoholic hepatitis: A potential silver lining? Liver Transpl. 2018 03; 24(3):330-332. Morgan T. PMID: 29365343.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology. 2018 05; 67(5):1737-1753. Khanova E, Wu R, Wang W, Yan R, Chen Y, French SW, Llorente C, Pan SQ, Yang Q, Li Y, Lazaro R, Ansong C, Smith RD, Bataller R, Morgan T, Schnabl B, Tsukamoto H. PMID: 29108122.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    25. Expression of proteins upregulated in hepatocellular carcinoma in patients with alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH): An immunohistochemical analysis of candidate proteins. Exp Mol Pathol. 2018 04; 104(2):125-129. Lu JG, Nguyen L, Samadzadeh S, Masouminia M, Mendoza A, Sweeney O, Tillman B, Afifyan N, Morgan T, French BA, French SW. PMID: 29425759.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    26. Alcoholic hepatitis versus non-alcoholic steatohepatitis: Levels of expression of some proteins involved in tumorigenesis. Exp Mol Pathol. 2018 02; 104(1):45-49. Nguyen L, Masouminia M, Mendoza A, Samadzadeh S, Tillman B, Morgan T, French B, French S. PMID: 29307797.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    27. Treatment of Alcoholic Liver Disease. Gastroenterol Hepatol (N Y). 2017 Jul; 13(7):425-427. Morgan TR. PMID: 28867971.
      View in: PubMed   Mentions:
    28. Autosomal dominant frontometaphyseal dysplasia: Delineation of the clinical phenotype. Am J Med Genet A. 2017 Jul; 173(7):1739-1746. Wade EM, Jenkins ZA, Daniel PB, Morgan T, Addor MC, Adés LC, Bertola D, Bohring A, Carter E, Cho TJ, de Geus CM, Duba HC, Fletcher E, Hadzsiev K, Hennekam RCM, Kim CA, Krakow D, Morava E, Neuhann T, Sillence D, Superti-Furga A, Veenstra-Knol HE, Wieczorek D, Wilson LC, Markie DM, Robertson SP. PMID: 28498505.
      View in: PubMed   Mentions: 3     Fields:    
    29. The association between implementation strategy use and the uptake of hepatitis C treatment in a national sample. Implement Sci. 2017 05 11; 12(1):60. Rogal SS, Yakovchenko V, Waltz TJ, Powell BJ, Kirchner JE, Proctor EK, Gonzalez R, Park A, Ross D, Morgan TR, Chartier M, Chinman MJ. PMID: 28494811.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    30. Race or genetic makeup for hepatitis C virus treatment decisions? Hepatology. 2017 06; 65(6):2124-2125. O'Brien TR, Kottilil S, Feld JJ, Morgan TR, Pfeiffer RM. PMID: 28100007.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    31. Trajectories of response to acupuncture for menopausal vasomotor symptoms: the Acupuncture in Menopause study. Menopause. 2017 02; 24(2):171-179. Avis NE, Coeytaux RR, Levine B, Isom S, Morgan T. PMID: 27676631.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials. PLoS One. 2016; 11(11):e0166036. Loftfield E, O'Brien TR, Pfeiffer RM, Howell CD, Horst R, Prokunina-Olsson L, Weinstein SJ, Albanes D, Morgan TR, Freedman ND. PMID: 27832143.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    33. Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection. Ann Hepatol. 2016 Nov-Dec 2016; 15(6):834-845. Rodriguez-Torres M, Lawitz E, Yangco B, Jeffers L, Han SH, Thuluvath PJ, Rustgi V, Harrison S, Ghalib R, Vierling JM, Luketic V, Zamor PJ, Ravendhran N, Morgan TR, Pearlman B, O'Brien C, Khallafi H, Pyrsopoulos N, Kong G, McPhee F, Yin PD, Hughes E, Treitel M. PMID: 27740516.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    34. Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia. Am J Hum Genet. 2016 08 04; 99(2):392-406. Wade EM, Daniel PB, Jenkins ZA, McInerney-Leo A, Leo P, Morgan T, Addor MC, Adès LC, Bertola D, Bohring A, Carter E, Cho TJ, Duba HC, Fletcher E, Kim CA, Krakow D, Morava E, Neuhann T, Superti-Furga A, Veenstra-Knol I, Wieczorek D, Wilson LC, Hennekam RC, Sutherland-Smith AJ, Strom TM, Wilkie AO, Brown MA, Duncan EL, Markie DM, Robertson SP. PMID: 27426733.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    35. Acupuncture in Menopause (AIM) study: a pragmatic, randomized controlled trial. Menopause. 2016 06; 23(6):626-37. Avis NE, Coeytaux RR, Isom S, Prevette K, Morgan T. PMID: 27023860.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple Comorbidities. Clin Gastroenterol Hepatol. 2017 02; 15(2):282-288. Ho SB, Monto A, Peyton A, Kaplan DE, Byrne S, Moon S, Copans A, Rossaro L, Roy A, Le H, Dvory-Sobol H, Zhu Y, Brainard DM, Guyer W, Shaikh O, Fuchs M, Morgan TR. PMID: 27237429.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    37. Improved Survival Among all Interferon-a-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders. Dig Dis Sci. 2016 06; 61(6):1744-56. Cozen ML, Ryan JC, Shen H, Cheung R, Kaplan DE, Pocha C, Brau N, Aytaman A, Schmidt WN, Pedrosa M, Anand BS, Chang KM, Morgan T, Monto A. PMID: 27059981.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Treatment of Severe Alcoholic Hepatitis. Gastroenterology. 2016 Jun; 150(8):1823-34. Thursz M, Morgan TR. PMID: 26948886.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    39. Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology. 2016 Apr; 150(4):785-90. Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, Mathurin P, McClain C, McCullough A, Mitchell MC, Morgan TR, Nagy L, Radaeva S, Sanyal A, Shah V, Szabo G. PMID: 26921783.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    40. Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial. JAMA. 2016 Jan 05; 315(1):36-46. Kitzman DW, Brubaker P, Morgan T, Haykowsky M, Hundley G, Kraus WE, Eggebeen J, Nicklas BJ. PMID: 26746456.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    41. Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial. Ann Intern Med. 2015 Dec 01; 163(11):818-26. Everson GT, Towner WJ, Davis MN, Wyles DL, Nahass RG, Thuluvath PJ, Etzkorn K, Hinestrosa F, Tong M, Rabinovitz M, McNally J, Brainard DM, Han L, Doehle B, McHutchison JG, Morgan T, Chung RT, Tran TT. PMID: 26551051.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    42. Predictors of Early Discontinuation of Pegylated Interferon for Reasons Other Than Lack of Efficacy in United States Veterans With Chronic Hepatitis C. Gastroenterol Nurs. 2015 Nov-Dec; 38(6):417-28. LaFleur J, Hoop R, Korner E, DuVall S, Morgan T, Pandya P, Han J, Knippenberg K, Nelson RE. PMID: 26626031.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1. N Engl J Med. 2015 Aug 20; 373(8):714-25. Wyles DL, Ruane PJ, Sulkowski MS, Dieterich D, Luetkemeyer A, Morgan TR, Sherman KE, Dretler R, Fishbein D, Gathe JC, Henn S, Hinestrosa F, Huynh C, McDonald C, Mills A, Overton ET, Ramgopal M, Rashbaum B, Ray G, Scarsella A, Yozviak J, McPhee F, Liu Z, Hughes E, Yin PD, Noviello S, Ackerman P. PMID: 26196502.
      View in: PubMed   Mentions: 116     Fields:    Translation:HumansCells
    44. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance. J Hepatol. 2015 Nov; 63(5):1103-10. O'Brien TR, Pfeiffer RM, Paquin A, Lang Kuhs KA, Chen S, Bonkovsky HL, Edlin BR, Howell CD, Kirk GD, Kuniholm MH, Morgan TR, Strickler HD, Thomas DL, Prokunina-Olsson L. PMID: 26186989.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    45. A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum a-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP. Cancer Prev Res (Phila). 2015 Sep; 8(9):864-72. Morgan TR, Osann K, Bottiglieri T, Pimstone N, Hoefs JC, Hu KQ, Hassanein T, Boyer TD, Kong L, Chen WP, Richmond E, Gonzalez R, Rodriguez LM, Meyskens FL. PMID: 26130251.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    46. Brief report: genetics of alcoholic cirrhosis-GenomALC multinational study. Alcohol Clin Exp Res. 2015 May; 39(5):836-42. Whitfield JB, Rahman K, Haber PS, Day CP, Masson S, Daly AK, Cordell HJ, Mueller S, Seitz HK, Liangpunsakul S, Westerhold C, Liang T, Lumeng L, Foroud T, Nalpas B, Mathurin P, Stickel F, Soyka M, Botwin GJ, Morgan TR, Seth D. PMID: 25872595.
      View in: PubMed   Mentions: 7     Fields:    
    47. Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis. Gastroenterology. 2015 Aug; 149(2):398-406.e8; quiz e16-7. Louvet A, Labreuche J, Artru F, Boursier J, Kim DJ, O'Grady J, Trépo E, Nahon P, Ganne-Carrié N, Naveau S, Diaz E, Gustot T, Lassailly G, Cannesson-Leroy A, Canva-Delcambre V, Dharancy S, Park SH, Moreno C, Morgan TR, Duhamel A, Mathurin P. PMID: 25935634.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    48. A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum. Cancer Prev Res (Phila). 2015 Mar; 8(3):222-30. Gillen DL, Meyskens FL, Morgan TR, Zell JA, Carroll R, Benya R, Chen WP, Mo A, Tucker C, Bhattacharya A, Huang Z, Arcilla M, Wong V, Chung J, Gonzalez R, Rodriguez LM, Szabo E, Rosenberg DW, Lipkin SM. PMID: 25604134.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    49. Quality of life and factors predictive of burden among primary caregivers of chronic liver disease patients. Ann Gastroenterol. 2015 Jan-Mar; 28(1):124-129. Nguyen DL, Chao D, Ma G, Morgan T. PMID: 25608915.
      View in: PubMed   Mentions:
    50. Corticosteroids can be used to treat alcoholic hepatitis after a recent upper gastrointestinal bleed. J Hepatol. 2015 Apr; 62(4):759-60. Morgan TR. PMID: 25543081.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Binge alcohol promotes hypoxic liver injury through a CYP2E1-HIF-1a-dependent apoptosis pathway in mice and humans. Free Radic Biol Med. 2014 Dec; 77:183-94. Yun JW, Son MJ, Abdelmegeed MA, Banerjee A, Morgan TR, Yoo SH, Song BJ. PMID: 25236742.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimals
    52. Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view. Hepatol Int. 2014 Sep 01; 8(2):447-51. Nguyen DL, Morgan T. PMID: 25525477.
      View in: PubMed   Mentions: 5     Fields:    
    53. The inflammasome in alcoholic hepatitis: Its relationship with Mallory-Denk body formation. Exp Mol Pathol. 2014 Oct; 97(2):305-13. Peng Y, French BA, Tillman B, Morgan TR, French SW. PMID: 25149528.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    54. Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). Am J Cardiol. 2014 Oct 15; 114(8):1217-22. Fatemi O, Yuriditsky E, Tsioufis C, Tsachris D, Morgan T, Basile J, Bigger T, Cushman W, Goff D, Soliman EZ, Thomas A, Papademetriou V. PMID: 25159234.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    55. TLR3/4 signaling is mediated via the NF?B-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies. Exp Mol Pathol. 2014 Oct; 97(2):234-40. Liu H, Li J, Tillman B, Morgan TR, French BA, French SW. PMID: 24997224.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    56. Update on recently approved treatments for hepatitis C. Curr Treat Options Gastroenterol. 2014 Jun; 12(2):211-28. Chao D, Botwin GJ, Morgan TR. PMID: 24648040.
      View in: PubMed   Mentions:
    57. High rates of early treatment discontinuation in hepatitis C-infected US veterans. BMC Res Notes. 2014 Apr 24; 7:266. LaFleur J, Hoop R, Morgan T, DuVall SL, Pandya P, Korner E, Knippenberg K, Hayden C, Nelson RE. PMID: 24758162.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    58. Predicting Discontinuation of Pegylated Interferon as a Result of Lack of Efficacy in United States Veterans With Chronic Hepatitis C on Dual Therapy. Ann Pharmacother. 2014 Jul; 48(7):826-836. Nelson RE, Hoop R, Korner E, DuVall S, Hayden CL, Knippenberg K, Morgan T, Pandya P, Han J, LaFleur J. PMID: 24760408.
      View in: PubMed   Mentions: 1     Fields:    
    59. Bacterial infections in cirrhosis. Hepatol Int. 2014 Sep; 8 Suppl 2:467-74. Botwin GJ, Morgan TR. PMID: 26201326.
      View in: PubMed   Mentions: 6     Fields:    
    60. Hepatitis C genotype 1 virus with low viral load and rapid virologic response to peginterferon/ribavirin obviates a protease inhibitor. Hepatology. 2014 Jun; 59(6):2423-4. Wang AS, Pfeiffer RM, Morgan TR, O'Brien TR. PMID: 24122888.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    61. Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development. Nat Genet. 2013 Nov; 45(11):1300-8. Cappello S, Gray MJ, Badouel C, Lange S, Einsiedler M, Srour M, Chitayat D, Hamdan FF, Jenkins ZA, Morgan T, Preitner N, Uster T, Thomas J, Shannon P, Morrison V, Di Donato N, Van Maldergem L, Neuhann T, Newbury-Ecob R, Swinkells M, Terhal P, Wilson LC, Zwijnenburg PJ, Sutherland-Smith AJ, Black MA, Markie D, Michaud JL, Simpson MA, Mansour S, McNeill H, Götz M, Robertson SP. PMID: 24056717.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansAnimalsCells
    62. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease. Nutr Res. 2013 Nov; 33(11):932-41. Kathirvel E, Morgan K, French SW, Morgan TR. PMID: 24176233.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    63. Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial. Gastroenterology. 2013 Nov; 145(5):1035-1044.e5. Poordad F, Lawitz E, Reddy KR, Afdhal NH, Hézode C, Zeuzem S, Lee SS, Calleja JL, Brown RS, Craxi A, Wedemeyer H, Nyberg L, Nelson DR, Rossaro L, Balart L, Morgan TR, Bacon BR, Flamm SL, Kowdley KV, Deng W, Koury KJ, Pedicone LD, Dutko FJ, Burroughs MH, Alves K, Wahl J, Brass CA, Albrecht JK, Sulkowski MS. PMID: 23924660.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    64. Treatment of alcoholic hepatitis. Clin Liver Dis (Hoboken). 2013 Apr; 2(2):84-88. Morgan TR, Chao D, Botwin G. PMID: 30992831.
      View in: PubMed   Mentions:
    65. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet. 2013 Feb; 45(2):164-71. Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I, Chen S, Brand N, Tarway M, Liu L, Sheikh F, Astemborski J, Bonkovsky HL, Edlin BR, Howell CD, Morgan TR, Thomas DL, Rehermann B, Donnelly RP, O'Brien TR. PMID: 23291588.
      View in: PubMed   Mentions: 286     Fields:    Translation:HumansCells
    66. Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study. J Psychosom Res. 2013 Jan; 74(1):57-63. Loftis JM, Patterson AL, Wilhelm CJ, McNett H, Morasco BJ, Huckans M, Morgan T, Saperstein S, Asghar A, Hauser P. PMID: 23272989.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    67. Vascular and connective tissue anomalies associated with X-linked periventricular heterotopia due to mutations in Filamin A. Eur J Hum Genet. 2013 May; 21(5):494-502. Reinstein E, Frentz S, Morgan T, García-Miñaúr S, Leventer RJ, McGillivray G, Pariani M, van der Steen A, Pope M, Holder-Espinasse M, Scott R, Thompson EM, Robertson T, Coppin B, Siegel R, Bret Zurita M, Rodríguez JI, Morales C, Rodrigues Y, Arcas J, Saggar A, Horton M, Zackai E, Graham JM, Rimoin DL, Robertson SP. PMID: 23032111.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    68. Alcoholic liver disease - Hepatocellular carcinoma transformation. J Gastrointest Oncol. 2012 Sep; 3(3):174-81. French SW, Lee J, Zhong J, Morgan TR, Buslon V, Lungo W, French BA. PMID: 22943009.
      View in: PubMed   Mentions:
    69. Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C. Am J Gastroenterol. 2012 Sep; 107(9):1388-98. Morishima C, Shiffman ML, Dienstag JL, Lindsay KL, Szabo G, Everson GT, Lok AS, Di Bisceglie AM, Ghany MG, Naishadham D, Morgan TR, Wright EC. PMID: 22688849.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    70. Factors that predict response of patients with hepatitis C virus infection to boceprevir. Gastroenterology. 2012 Sep; 143(3):608-618.e5. Poordad F, Bronowicki JP, Gordon SC, Zeuzem S, Jacobson IM, Sulkowski MS, Poynard T, Morgan TR, Molony C, Pedicone LD, Sings HL, Burroughs MH, Sniukiene V, Boparai N, Goteti VS, Brass CA, Albrecht JK, Bacon BR. PMID: 22626609.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCellsCTClinical Trials
    71. Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office. Am J Gastroenterol. 2012 May; 107(5):669-89; quiz 690. Yee HS, Chang MF, Pocha C, Lim J, Ross D, Morgan TR, Monto A. PMID: 22525303.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    72. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus. Pharmacotherapy. 2012 May; 32(5):420-6. McFarland M, Davis K, Wallace J, Wan J, Cassidy R, Morgan T, Venugopal D. PMID: 22488512.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    73. Management of Adverse Events During the Treatment of Chronic Hepatitis C Infection. Clin Liver Dis (Hoboken). 2012 Apr; 1(2):54-57. Nguyen DL, Morgan TR. PMID: 25688295.
      View in: PubMed   Mentions:
    74. Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial. Hepatology. 2012 Apr; 55(4):1019-29. Everson GT, Shiffman ML, Hoefs JC, Morgan TR, Sterling RK, Wagner DA, Lauriski S, Curto TM, Stoddard A, Wright EC. PMID: 22030902.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    75. Aging reduces left atrial performance during adrenergic stress in middle aged and older patients. Cardiol J. 2012; 19(1):45-52. Jeevanantham V, Chughtai H, Little WC, Morgan T, Kitzman DW, Hamilton CA, Hundley WG. PMID: 22298167.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    76. Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C. Am J Gastroenterol. 2012 Jan; 107(1):64-74. Sterling RK, Wright EC, Morgan TR, Seeff LB, Hoefs JC, Di Bisceglie AM, Dienstag JL, Lok AS. PMID: 21931376.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    77. Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. Hepatology. 2011 Aug; 54(2):434-42. Lok AS, Everhart JE, Di Bisceglie AM, Kim HY, Hussain M, Morgan TR. PMID: 21374690.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    78. An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C. PLoS One. 2011; 6(7):e20904. O'Brien TR, Everhart JE, Morgan TR, Lok AS, Chung RT, Shao Y, Shiffman ML, Dotrang M, Sninsky JJ, Bonkovsky HL, Pfeiffer RM. PMID: 21760886.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    79. A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C. Hepatology. 2011 Aug; 54(2):396-405. Dienstag JL, Ghany MG, Morgan TR, Di Bisceglie AM, Bonkovsky HL, Kim HY, Seeff LB, Szabo G, Wright EC, Sterling RK, Everson GT, Lindsay KL, Lee WM, Lok AS, Morishima C, Stoddard AM, Everhart JE. PMID: 21520194.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    80. Testing beneficial therapy in human cirrhosis using animal models of cirrhosis. Dig Dis Sci. 2011 Apr; 56(4):929-30. Hoefs JC, Morgan T, Ilagan BJ. PMID: 21365242.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    81. Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon. Hepatology. 2011 Apr; 53(4):1100-8. Di Bisceglie AM, Stoddard AM, Dienstag JL, Shiffman ML, Seeff LB, Bonkovsky HL, Morishima C, Wright EC, Snow KK, Lee WM, Fontana RJ, Morgan TR, Ghany MG. PMID: 21480316.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    82. Coronary calcium score and prediction of all-cause mortality in diabetes: the diabetes heart study. Diabetes Care. 2011 May; 34(5):1219-24. Agarwal S, Morgan T, Herrington DM, Xu J, Cox AJ, Freedman BI, Carr JJ, Bowden DW. PMID: 21398528.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    83. Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C. Gastroenterology. 2011 May; 140(5):1490-500.e3. Lambrecht RW, Sterling RK, Naishadham D, Stoddard AM, Rogers T, Morishima C, Morgan TR, Bonkovsky HL. PMID: 21335007.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    84. Chemoprevention of hepatocellular carcinoma in chronic hepatitis C. Recent Results Cancer Res. 2011; 188:85-99. Morgan TR. PMID: 21253791.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    85. IL28B-genotype testing now and in the era of direct-acting antiviral agents. Clin Gastroenterol Hepatol. 2011 Apr; 9(4):293-4. Morgan TR, O'Brien TR. PMID: 21185399.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    86. Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C. Am J Gastroenterol. 2011 May; 106(5):884-93. Fontana RJ, Sanyal AJ, Ghany MG, Bonkovsky HL, Morgan TR, Litman HJ, Reid AE, Lee WM, Naishadham D. PMID: 21139575.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    87. Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C. Gastroenterology. 2011 Mar; 140(3):840-9; quiz e12. Lok AS, Everhart JE, Wright EC, Di Bisceglie AM, Kim HY, Sterling RK, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Morgan TR. PMID: 21129375.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCells
    88. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011 Feb; 60(2):255-60. Mathurin P, O'Grady J, Carithers RL, Phillips M, Louvet A, Mendenhall CL, Ramond MJ, Naveau S, Maddrey WC, Morgan TR. PMID: 20940288.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    89. Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology. 2010 Sep; 52(3):833-44. Morgan TR, Ghany MG, Kim HY, Snow KK, Shiffman ML, De Santo JL, Lee WM, Di Bisceglie AM, Bonkovsky HL, Dienstag JL, Morishima C, Lindsay KL, Lok AS. PMID: 20564351.
      View in: PubMed   Mentions: 121     Fields:    Translation:Humans
    90. Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine. Am J Physiol Gastrointest Liver Physiol. 2010 Nov; 299(5):G1068-77. Kathirvel E, Morgan K, Nandgiri G, Sandoval BC, Caudill MA, Bottiglieri T, French SW, Morgan TR. PMID: 20724529.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    91. Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver. J Gastroenterol Hepatol. 2010 Jun; 25(6):1136-43. Kathirvel E, Chen P, Morgan K, French SW, Morgan TR. PMID: 20594230.
      View in: PubMed   Mentions: 25     Fields:    Translation:AnimalsCells
    92. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol. 2010 Oct; 8(10):877-83. Seeff LB, Everson GT, Morgan TR, Curto TM, Lee WM, Ghany MG, Shiffman ML, Fontana RJ, Di Bisceglie AM, Bonkovsky HL, Dienstag JL. PMID: 20362695.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCTClinical Trials
    93. Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C. Gastroenterology. 2010 Jun; 138(7):2321-31, 2331.e1-2. Fontana RJ, Sanyal AJ, Ghany MG, Lee WM, Reid AE, Naishadham D, Everson GT, Kahn JA, Di Bisceglie AM, Szabo G, Morgan TR, Everhart JE. PMID: 20211180.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    94. Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial. Hepatology. 2009 Dec; 50(6):1738-49. Goodman ZD, Stoddard AM, Bonkovsky HL, Fontana RJ, Ghany MG, Morgan TR, Wright EC, Brunt EM, Kleiner DE, Shiffman ML, Everson GT, Lindsay KL, Dienstag JL, Morishima C. PMID: 19824074.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    95. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology. 2010 Feb; 138(2):493-502. Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, Di Bisceglie AM, Morgan TR, Kim HY, Lee WM, Bonkovsky HL, Dienstag JL. PMID: 19852963.
      View in: PubMed   Mentions: 147     Fields:    Translation:Humans
    96. Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gastroenterology. 2010 Jan; 138(1):136-46. Ghany MG, Lok AS, Everhart JE, Everson GT, Lee WM, Curto TM, Wright EC, Stoddard AM, Sterling RK, Di Bisceglie AM, Bonkovsky HL, Morishima C, Morgan TR, Dienstag JL. PMID: 19766643.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    97. Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2009 Sep; 21(9):973-83. Kathirvel E, Morgan K, French SW, Morgan TR. PMID: 19307976.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    98. Alcoholic hepatitis. N Engl J Med. 2009 Jun 25; 360(26):2758-69. Lucey MR, Mathurin P, Morgan TR. PMID: 19553649.
      View in: PubMed   Mentions: 229     Fields:    Translation:Humans
    99. Cytotoxic T cell immunity against the non-immunogenic, murine, hepatocellular carcinoma Hepa1-6 is directed towards the novel alternative form of macrophage colony stimulating factor. Cell Immunol. 2009; 259(2):117-27. Ge L, Zhang JG, Samathanam CA, Delgado C, Tarbiyat-Boldaji M, Dan Q, Hoa N, Nguyen TV, Alipanah R, Pham JT, Sanchez R, Wepsic HT, Morgan TR, Jadus MR. PMID: 19615673.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    100. Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology. 2009 Jun; 49(6):1847-58. Welzel TM, Morgan TR, Bonkovsky HL, Naishadham D, Pfeiffer RM, Wright EC, Hutchinson AA, Crenshaw AT, Bashirova A, Carrington M, Dotrang M, Sterling RK, Lindsay KL, Fontana RJ, Lee WM, Di Bisceglie AM, Ghany MG, Gretch DR, Chanock SJ, Chung RT, O'Brien TR. PMID: 19434718.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    101. Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. Gastroenterology. 2009 Aug; 137(2):549-57. Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT, Bonkovsky HL, Ghany MG. PMID: 19445938.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    102. Re: Palliative sedation at home. J Palliat Care. 2009; 25(3):229; author reply 229. Morgan TR, Denholm MJ, Lawton S. PMID: 19824286.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    103. The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model. J Hepatol. 2009 Mar; 50(3):572-83. Butura A, Nilsson K, Morgan K, Morgan TR, French SW, Johansson I, Schuppe-Koistinen I, Ingelman-Sundberg M. PMID: 19157621.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimals
    104. Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis. Nat Genet. 2009 Jan; 41(1):95-100. Jenkins ZA, van Kogelenberg M, Morgan T, Jeffs A, Fukuzawa R, Pearl E, Thaller C, Hing AV, Porteous ME, Garcia-Miñaur S, Bohring A, Lacombe D, Stewart F, Fiskerstrand T, Bindoff L, Berland S, Adès LC, Tchan M, David A, Wilson LC, Hennekam RC, Donnai D, Mansour S, Cormier-Daire V, Robertson SP. PMID: 19079258.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    105. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med. 2008 Dec 04; 359(23):2429-41. Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL. PMID: 19052125.
      View in: PubMed   Mentions: 134     Fields:    Translation:HumansCells
    106. Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C. Hepatology. 2008 Nov; 48(5):1412-9. Morishima C, Morgan TR, Everhart JE, Wright EC, Apodaca MC, Gretch DR, Shiffman ML, Everson GT, Lindsay KL, Lee WM, Lok AS, Dienstag JL, Ghany MG, Curto TM. PMID: 18816437.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    107. Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirin. Hepatology. 2008 Oct; 48(4):1033-43. Fried MW, Jensen DM, Rodriguez-Torres M, Nyberg LM, Di Bisceglie AM, Morgan TR, Pockros PJ, Lin A, Cupelli L, Duff F, Wang K, Nelson DR. PMID: 18697207.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    108. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009 Jan; 136(1):138-48. Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Goodman ZD. PMID: 18848939.
      View in: PubMed   Mentions: 169     Fields:    Translation:Humans
    109. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2008 Sep; 20(9):843-54. Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR. PMID: 18794597.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    110. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice? J Clin Gastroenterol. 2008 Aug; 42(7):827-34. Cheung RC, Currie S, Shen H, Bini EJ, Ho SB, Anand BS, Hu KQ, Wright TL, Morgan TR. PMID: 18285716.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    111. DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial. J Hepatol. 2008 Oct; 49(4):548-56. Morgan TR, Lambrecht RW, Bonkovsky HL, Chung RT, Naishadham D, Sterling RK, Fontana RJ, Lee WM, Ghany MG, Wright EC, O'Brien TR. PMID: 18619701.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    112. Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C. Clin Gastroenterol Hepatol. 2008 Feb; 6(2):234-41. Lindsay KL, Morishima C, Wright EC, Dienstag JL, Shiffman ML, Everson GT, Lok AS, Bonkovsky HL, Lee WM, Morgan TR, Ghany MG. PMID: 18237873.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    113. Commentary on 'designing phase II studies in cancer with time-to-event endpoints'. Clin Trials. 2008; 5(3):222-3; discussion 223-4. Case D, Morgan T. PMID: 18559410.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    114. Seventy-two weeks of peginterferon and ribavirin for patients with partial early virologic response? Hepatology. 2007 Dec; 46(6):1671-4. Hoefs JC, Morgan TR. PMID: 18046713.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    115. Effect of simvastatin (80 mg) on coronary and abdominal aortic arterial calcium (from the coronary artery calcification treatment with zocor [CATZ] study). Am J Cardiol. 2007 Jun 15; 99(12):1714-7. Terry JG, Carr JJ, Kouba EO, Davis DH, Menon L, Bender K, Chandler ET, Morgan T, Crouse JR. PMID: 17560880.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    116. Management of alcoholic hepatitis. Gastroenterol Hepatol (N Y). 2007 Feb; 3(2):97-9. Morgan TR. PMID: 21960817.
      View in: PubMed   Mentions:
    117. Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. Clin Gastroenterol Hepatol. 2007 Feb; 5(2):245-54. Lok AS, Everhart JE, Chung RT, Padmanabhan L, Greenson JK, Shiffman ML, Everson GT, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Ghany MG, Morishima C. PMID: 17296533.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    118. Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans. Dig Dis Sci. 2007 Feb; 52(2):570-8. Hu KQ, Currie SL, Shen H, Cheung RC, Ho SB, Bini EJ, McCracken JD, Morgan T, Bräu N, Schmidt WN, Jeffers L, Wright TL. PMID: 17226072.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    119. Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment. Clin Gastroenterol Hepatol. 2007 Jan; 5(1):124-9. Reddy KR, Shiffman ML, Morgan TR, Zeuzem S, Hadziyannis S, Hamzeh FM, Wright TL, Fried M. PMID: 17196435.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    120. Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. J Hepatol. 2007 Mar; 46(3):420-31. Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, Kulig CC, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG, Gretch DR. PMID: 17196293.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    121. Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C. Gastroenterology. 2007 Jan; 132(1):103-12. Shiffman ML, Ghany MG, Morgan TR, Wright EC, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Gretch DR. PMID: 17241864.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    122. HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial. Hepatology. 2006 Aug; 44(2):360-7. Morishima C, Morgan TR, Everhart JE, Wright EC, Shiffman ML, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Gretch DR. PMID: 16871570.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    123. Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis. Am J Gastroenterol. 2006 Jul; 101(7):1500-8. Lieber CS, Weiss DG, Morgan TR, Paronetto F. PMID: 16863553.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    124. Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy. Hepatology. 2006 May; 43(5):954-60. Jensen DM, Morgan TR, Marcellin P, Pockros PJ, Reddy KR, Hadziyannis SJ, Ferenci P, Ackrill AM, Willems B. PMID: 16628671.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCells
    125. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006; 3(2):47-52. Chen SL, Morgan TR. PMID: 16614742.
      View in: PubMed   Mentions: 179     Fields:    
    126. How useful and accurate is the new Glasgow alcoholic hepatitis scoring system? Nat Clin Pract Gastroenterol Hepatol. 2006 Jan; 3(1):14-5. Morgan TR. PMID: 16397604.
      View in: PubMed   Mentions: 1     Fields:    
    127. Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol. 2005 Sep; 43(3):434-41. Di Bisceglie AM, Sterling RK, Chung RT, Everhart JE, Dienstag JL, Bonkovsky HL, Wright EC, Everson GT, Lindsay KL, Lok AS, Lee WM, Morgan TR, Ghany MG, Gretch DR. PMID: 16136646.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCTClinical Trials
    128. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology. 2005 Aug; 42(2):282-92. Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, Everhart JE, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Dienstag JL, Morishima C. PMID: 15986415.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    129. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol. 2005 Aug; 100(8):1772-9. Bini EJ, Bräu N, Currie S, Shen H, Anand BS, Hu KQ, Jeffers L, Ho SB, Johnson D, Schmidt WN, King P, Cheung R, Morgan TR, Awad J, Pedrosa M, Chang KM, Aytaman A, Simon F, Hagedorn C, Moseley R, Ahmad J, Mendenhall C, Waters B, Strader D, Sasaki AW, Rossi S, Wright TL. PMID: 16086714.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    130. Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival. Gastroenterology. 2005 Apr; 128(4):882-90. Morgan TR, Weiss DG, Nemchausky B, Schiff ER, Anand B, Simon F, Kidao J, Cecil B, Mendenhall CL, Nelson D, Lieber C, Pedrosa M, Jeffers L, Bloor J, Lumeng L, Marsano L, McClain C, Mishra G, Myers B, Leo M, Ponomarenko Y, Taylor D, Chedid A, French S, Kanel G, Murray N, Pinto P, Fong TL, Sather MR. PMID: 15825072.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    131. CYP2E1 inhibition enhances mallory body formation. Exp Mol Pathol. 2005 Jun; 78(3):207-11. Bardag-Gorce F, Wilson L, Nan L, Li J, French BA, Morgan TR, Morgan K, French SW. PMID: 15924872.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    132. Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med. 2005 Mar 10; 6(1):3. Espeland MA, O'leary DH, Terry JG, Morgan T, Evans G, Mudra H. PMID: 15760471.
      View in: PubMed   Mentions:
    133. Alcohol and hepatitis C. Dig Dis. 2005; 23(3-4):285-96. Jamal MM, Saadi Z, Morgan TR. PMID: 16508293.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    134. Alcohol and hepatocellular carcinoma. Gastroenterology. 2004 Nov; 127(5 Suppl 1):S87-96. Morgan TR, Mandayam S, Jamal MM. PMID: 15508108.
      View in: PubMed   Mentions: 131     Fields:    Translation:HumansCells
    135. Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders. Control Clin Trials. 2004 Oct; 25(5):472-92. Lee WM, Dienstag JL, Lindsay KL, Lok AS, Bonkovsky HL, Shiffman ML, Everson GT, Di Bisceglie AM, Morgan TR, Ghany MG, Morishima C, Wright EC, Everhart JE. PMID: 15465617.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCTClinical Trials
    136. Caloric restriction and cardiovascular aging in cynomolgus monkeys (Macaca fascicularis): metabolic, physiologic, and atherosclerotic measures from a 4-year intervention trial. J Gerontol A Biol Sci Med Sci. 2004 Oct; 59(10):1007-14. Cefalu WT, Wang ZQ, Bell-Farrow AD, Collins J, Morgan T, Wagner JD. PMID: 15528768.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    137. Epidemiology of alcoholic liver disease. Semin Liver Dis. 2004 Aug; 24(3):217-32. Mandayam S, Jamal MM, Morgan TR. PMID: 15349801.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    138. Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology. 2004 Apr; 126(4):1015-23; discussion 947. Shiffman ML, Di Bisceglie AM, Lindsay KL, Morishima C, Wright EC, Everson GT, Lok AS, Morgan TR, Bonkovsky HL, Lee WM, Dienstag JL, Ghany MG, Goodman ZD, Everhart JE. PMID: 15057741.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansCTClinical Trials
    139. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med. 2004 Mar 02; 140(5):346-55. Hadziyannis SJ, Sette H, Morgan TR, Balan V, Diago M, Marcellin P, Ramadori G, Bodenheimer H, Bernstein D, Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM. PMID: 14996676.
      View in: PubMed   Mentions: 624     Fields:    Translation:HumansCellsCTClinical Trials
    140. Mutations in the gene encoding filamin B disrupt vertebral segmentation, joint formation and skeletogenesis. Nat Genet. 2004 Apr; 36(4):405-10. Krakow D, Robertson SP, King LM, Morgan T, Sebald ET, Bertolotto C, Wachsmann-Hogiu S, Acuna D, Shapiro SS, Takafuta T, Aftimos S, Kim CA, Firth H, Steiner CE, Cormier-Daire V, Superti-Furga A, Bonafe L, Graham JM, Grix A, Bacino CA, Allanson J, Bialer MG, Lachman RS, Rimoin DL, Cohn DH. PMID: 14991055.
      View in: PubMed   Mentions: 73     Fields:    Translation:Cells
    141. Liver disease in alcohol and hepatitis C. Best Pract Res Clin Gastroenterol. 2003 Aug; 17(4):649-62. Jamal MM, Morgan TR. PMID: 12828960.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    142. The Arthritis, Diet and Activity Promotion Trial (ADAPT): design, rationale, and baseline results. Control Clin Trials. 2003 Aug; 24(4):462-80. Miller GD, Rejeski WJ, Williamson JD, Morgan T, Sevick MA, Loeser RF, Ettinger WH, Messier SP. PMID: 12865040.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    143. Hepatitis C and alcohol: fundamental and translational research directions. Alcohol Clin Exp Res. 2003 Apr; 27(4):726-31. Morgan TR, Brenner D, Everhart J, French SW, Fried MW, Gretch DR, Koziel MJ, McClain CJ, Peters MG, Weinman SA, Lucas DL. PMID: 12711937.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    144. Associations of extracranial carotid atherosclerosis progression with coronary status and risk factors in patients with and without coronary artery disease. Circulation. 2002 Oct 15; 106(16):2061-6. Crouse JR, Tang R, Espeland MA, Terry JG, Morgan T, Mercuri M. PMID: 12379574.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    145. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol. 2002 Sep; 97(9):2391-7. Strader DB, Bacon BR, Lindsay KL, La Brecque DR, Morgan T, Wright EC, Allen J, Khokar MF, Hoofnagle JH, Seeff LB. PMID: 12358262.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    146. Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology. 2002 Jul; 36(1):122-34. Morgan K, French SW, Morgan TR. PMID: 12085356.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    147. Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin. Hepatology. 2002 Mar; 35(3):688-93. McHutchison JG, Poynard T, Esteban-Mur R, Davis GL, Goodman ZD, Harvey J, Ling MH, Garaud JJ, Albrecht JK, Patel K, Dienstag JL, Morgan T. PMID: 11870385.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    Timothy's Networks
    Concepts (527)
    Derived automatically from this person's publications.
    _
    Co-Authors (27)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _